Do Not Administer Nohist-DM to This Child
This child weighing 9.98 kg (approximately 22 lbs) is under 6 years of age and should NOT receive Nohist-DM according to the FDA-approved labeling, which explicitly states "Ask your doctor" for children under 6 years 1. The product is not approved for routine use in this age group without specific physician guidance.
Critical Safety Considerations
Age-Based Contraindication
The FDA labeling for Nohist-DM clearly delineates dosing by age, not weight 1:
- Children under 6 years: Requires physician consultation before use
- Children 6 to under 12 years: 2.5 mL (1/2 teaspoon) every 4 hours
- Children over 12 years and adults: 5 mL (1 teaspoon) every 4 hours
A child weighing 9.98 kg is likely between 1-3 years old based on standard pediatric growth curves, placing them well below the 6-year threshold.
Why This Restriction Exists
Pharmacokinetic differences in young children make standard dosing potentially dangerous:
Chlorpheniramine (4 mg/5 mL in this formulation): While pediatric pharmacokinetic data show a half-life of 13.1 hours and large volume of distribution (7.0 L/kg) in children 6-16 years 2, younger children may have unpredictable clearance and increased risk of paradoxical excitation or excessive sedation 1.
Phenylephrine (10 mg/5 mL): Pediatric studies demonstrate age-dependent clearance patterns, with younger children showing different pharmacokinetic profiles 3. The concentration in Nohist-DM is notably higher than typical pediatric formulations.
Dextromethorphan (15 mg/5 mL): Metabolism varies significantly with age due to developing hepatic enzyme systems 4.
Specific Risks in Young Children
The FDA labeling warns of several concerns particularly relevant to children under 6 1:
- Marked drowsiness with potential respiratory depression
- Paradoxical excitability, especially common in young children
- Unpredictable response due to immature drug metabolism
- Overdose risk from the combination formulation
Clinical Recommendation
If this child requires treatment for cough/cold symptoms:
Consult the prescribing physician before administering any dose, as mandated by the product labeling 1
Consider non-pharmacologic interventions as first-line for children under 6 years
If medication is deemed necessary, the physician should:
- Calculate an individualized dose based on the child's specific age, weight, and clinical condition
- Consider single-ingredient products rather than combination therapy to minimize exposure
- Monitor closely for adverse effects, particularly sedation and excitability
Never exceed 6 doses in 24 hours if any dose is prescribed 1
Common Pitfall to Avoid
Do not extrapolate adult or older pediatric dosing to young children. The absence of approved dosing for children under 6 years reflects genuine safety concerns, not simply lack of data. Pediatric patients require individualized pharmacokinetic considerations based on organ maturity and cannot be treated as "small adults" 4.
The safest approach: Do not administer without explicit physician guidance for this age group.